We are live on !
Find out more
Pratt Collard Advisory Partners Portfolio holdings
AUM
$150M
Turnover
6%
1-Year Est. Return
51.02%
This Fund
S&P 500
This Quarter Est. Return
+6.72%
1 Year Est. Return
+51.02%
3 Year Est. Return
+91.71%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$150M
AUM Growth
+$10.2M
(+7.3%)
Cap. Flow
+$1.84M
Cap. Flow % of AUM
Cap. Flow %
1.23%
Top 10 Holdings %
Top 10 Hldgs %
39.78%
Holding
100
New
3
Increased
32
Reduced
35
Closed
3
Avg Time Held
2.7
years
Top 10 Avg Time Held
2.6
years
Top 20 Avg Time Held
2.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Digimarc Corp
DMRC
|
+$344K |
| 2 |
Cisco
CSCO
|
+$263K |
| 3 |
CVS Health
CVS
|
+$260K |
| 4 |
Air Products & Chemicals
APD
|
+$258K |
| 5 |
West Pharmaceutical
WST
|
+$226K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$344K |
| 2 |
KSU
Kansas City Southern
KSU
|
+$302K |
| 3 |
Emerson Electric
EMR
|
+$249K |
| 4 |
State Street
STT
|
+$202K |
| 5 |
Ovintiv
OVV
|
+$121K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.65% |
| 2 | Consumer Staples | 18.73% |
| 3 | Healthcare | 17.19% |
| 4 | Financials | 13.77% |
| 5 | Communication Services | 8.97% |
Similar funds
GAM
WFWM
TCM
LWPC
RGM
SFSIG
Pratt Collard Advisory Partners's Q2 2021 Portfolio in Review
As of Q2 2021, Pratt Collard Advisory Partners held 100 positions worth $150M, up 7.3% from $140M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Pratt Collard Advisory Partners's Q2 2021 filing shows 3 new, 32 increased, 35 reduced and 3 closed positions. Its largest new stake was West Pharmaceutical: 685 shares worth $246K. The largest sale was AbbVie, an estimated $344K.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Consumer Staples and Healthcare.
- Pratt Collard Advisory Partners's largest Q2 2021 buy was West Pharmaceutical: 685 shares worth $246K.
- Pratt Collard Advisory Partners added most to Digimarc Corp in Q2 2021, an estimated $344K increase.
- Pratt Collard Advisory Partners's biggest Q2 2021 reduction was AbbVie, cutting an estimated $344K.
- Pratt Collard Advisory Partners fully exited Kansas City Southern in Q2 2021, selling an estimated $302K.
- Pratt Collard Advisory Partners's ten largest holdings make up 40% of its $150M portfolio in Q2 2021.
- Pratt Collard Advisory Partners opened 3 new positions and closed 3 in Q2 2021.
- Pratt Collard Advisory Partners's portfolio value rose 7.3% quarter-over-quarter to $150M.
Based on Pratt Collard Advisory Partners's 13F filing for Q2 2021, filed 14 Jul 2021.